Patent directory · USPTO A61K / A61P
Patents matching “treatment”
2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11354990
Treatment of kidney diseases associated with elevated AVP
granted -
US 11344538
Methods for the treatment of myopia
granted -
US 11344707
Devices for applying a topical treatment
granted -
US 11344575
Vascular calcification prevention and treatment
granted -
US 11344569
Treatment of sleep-wake disorders and neurodegenerative disease comprising modified resistant maltodextrin
granted -
US 11339213
Methods and compositions for treatment of cancer
granted -
US 11338026
Identification of immunologically protective neo-epitopes for the treatment of cancers
granted -
US 11337968
Phenylquinoline compositions for treatment of ocular disorders and conditions
granted -
US 11331395
Hydrogel prodrug for treatment
granted -
US 11331333
Treatment of aberrant fibroblast proliferation
granted -
US 11331332
Treatment of increased lipid levels with sterol regulatory element binding protein cleavage-activating protein (SCAP) inhibitors
granted -
US 11324811
Optimization of enzyme replacement therapy for treatment of homocystinuria
granted -
US 11324735
Method of treatment with tradipitant
granted -
US 11324822
Combination of HDAC inhibitor and anti-PD-1 antibody for treatment of cancer
granted -
US 11324820
Methods for the treatment of subjects having a hepatitis b virus (HBV) infection
granted -
US 11326182
Compositions for the treatment of disease
granted -
US 11327083
Treatment and differential diagnosis of Cushing's disease and ectopic Cushing's syndrome
granted -
US 11324753
Method of treatment of attention deficit/hyperactivity disorder (ADHD)
granted -
US 11319302
PRC1 inhibitors and methods of treatment therewith
granted -
US 11318164
Immunotherapeutic treatment method using an interleukin-2 receptor beta-selective agonist in combination with adoptive cell transfer therapy
granted -
US 11311544
Treatment of congenital adrenal hyperplasia
granted -
US 11311541
Treatment of GVHD
granted -
US 11311581
Combination comprising spirulina and palmitoylethanolamide and/or salts or pharmaceutically acceptable derivatives thereof and their formulations, for use in the prevention and/or in the treatment of hyperactivated tissue conditions
granted -
US 11305002
Compositions and treatments for Haemophilus influenzae
granted